OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in cancer drug delivery based on AS1411 oriented nanomaterials
Xin Tong, Lu Ga, Jun Ai, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Advances in aptamer-mediated targeted delivery system for cancer treatment
Shiming He, Yue Du, Hongyu Tao, et al.
International Journal of Biological Macromolecules (2023) Vol. 238, pp. 124173-124173
Closed Access | Times Cited: 59

Aptamers as an approach to targeted cancer therapy
Fatemeh Mahmoudian, Azin Ahmari, Shiva Shabani, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 34

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 25

Advances in aptamer-based nuclear imaging
Wenyu Song, Yangmeihui Song, Qian Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2544-2559
Closed Access | Times Cited: 42

Anti-nucleolin aptamer AS1411: an advancing therapeutic
Alexander Van den Avont, Neelam Sharma-Walia
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 36

Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer
Dhruv Sanjanwala, Vandana Patravale
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103550-103550
Closed Access | Times Cited: 25

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 16

Synergistic Viro-chemoimmunotherapy in Breast Cancer Enabled by Bioengineered Immunostimulatory Exosomes and Dual-Targeted Coxsackievirus B3
Amirhossein Bahreyni, Yasir Mohamud, Sanaz Ashraf Nouhegar, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4241-4255
Open Access | Times Cited: 12

Repurposing AS1411 for constructing ANM-PROTACs
Xuekun Fu, Jin Li, Xinxin Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1290-1304.e7
Closed Access | Times Cited: 10

Cell membrane-inspired chitosan nanoparticles for prolonged circulation and tumor-targeted drug delivery
Mingzhu Xie, Jing Zhao, Xikang Feng, et al.
International Journal of Biological Macromolecules (2025) Vol. 304, pp. 140934-140934
Closed Access | Times Cited: 2

Unravelling the therapeutic properties of aptamer-modified exosome nanocomposite
Simran Makkar, Niket Rana, Nitesh Priyadarshi, et al.
Advances in Colloid and Interface Science (2025), pp. 103517-103517
Closed Access | Times Cited: 1

Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer
Mahtab Razlansari, Somayeh Jafarinejad, Abbas Rahdar, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 7, pp. 1573-1598
Closed Access | Times Cited: 37

Aptamers used for molecular imaging and theranostics - recent developments
Lennart Bohrmann, Tobias Burghardt, Charles A. Haynes, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4010-4050
Open Access | Times Cited: 29

Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer
Francesco Puzzo, Chuanling Zhang, Bethany Powell Gray, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 383-397
Open Access | Times Cited: 22

Dual-targeted delivery of paclitaxel and indocyanine green with aptamer-modified ferritin for synergetic chemo-phototherapy
Kun Yang, Yixin Dong, Xun Li, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 229, pp. 113437-113437
Closed Access | Times Cited: 19

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
Suyanee Thongchot, Krittaya Aksonnam, Peti Thuwajit, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 3
Open Access | Times Cited: 19

DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors
Anastasia N. Shishparenok, Vitalina V. Furman, Dmitry D. Zhdanov
Cancers (2023) Vol. 15, Iss. 7, pp. 2151-2151
Open Access | Times Cited: 17

Nucleic acid aptamer based thermally oxidized porous silicon/zinc oxide microarray chip for detection of ochratoxin A in cereals
Jiayu Chen, Liyuan Zhang, Runzhong Yu
Food Chemistry (2024) Vol. 442, pp. 138384-138384
Closed Access | Times Cited: 7

AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging
Mahima Chauhan, Sonali, Saurabh Shekhar, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213833-213833
Closed Access | Times Cited: 6

Development and characterization of micelles for nucleolin-targeted co-delivery of docetaxel and upconversion nanoparticles for theranostic applications in brain cancer therapy
Mahima Chauhan, Rahul Pratap Singh, Sonali, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104808-104808
Closed Access | Times Cited: 13

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 13

Scouting the efficacy of targeted gold nanoparticles in the landscape of cancer therapy
Mahak Fatima, Garima Gupta, Swaranjeet Arora, et al.
European Polymer Journal (2024) Vol. 209, pp. 112924-112924
Closed Access | Times Cited: 4

AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes
Xiaoming Sun, Wenzi Zhang, Changlong Gou, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167211-167211
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top